EVRAZ plc (EVR.L)
| Previous close | 80.89 |
| Open | 81.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 81.00 - 81.00 |
| 52-week range | 0.81 - 523.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.182B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 0.42 |
| EPS (TTM) | 1.95 |
| Earnings date | 04 Aug 2022 |
| Forward dividend & yield | 0.76 (93.41%) |
| Ex-dividend date | 10 Mar 2022 |
| 1y target est | 7.18 |
- EQS Group
EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective
EVRAZ plc (EVR) EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 have become effective 28-Dec-2022 / 10:30 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT I
- EQS Group
EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024
EVRAZ plc (EVR) EVRAZ plc announces results of the Consent Solicitation for its outstanding U.S.$700,000,000 5.250 per cent. notes due 2024 23-Dec-2022 / 10:30 MSK Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDI
- EQS Group
EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective
EVRAZ plc (EVR) EVRAZ plc announces that the Appointment and the Amendments adopted as part of the Consent Solicitation for its outstanding notes due 2023 have become effective 19-Dec-2022 / 14:00 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR
